rNAPc2: Phase IIb started

NUVO began the single-arm, open-label, U.S. and Canadian Phase IIb ANTHEM/TIMI 32b trial in 50-100 patients. The first cohort of 25 patients will receive a half-dose regimen of unfractionated heparin ...